Baseline CD4(+) and expansion of gammadelta T cells correlate with response to durvalumab in triple-negative breast cancer patients

Clin Transl Med. 2024 Apr;14(4):e1617. doi: 10.1002/ctm2.1617.NO ABSTRACTPMID:38664548 | DOI:10.1002/ctm2.1617

Source: Clinical Breast Cancer - April 25, 2024 Category: Cancer & Oncology Authors: Chiara Massa Thomas Karn Karsten Weber Andreas Schneeweiss Claus Hanusch Jens Uwe Blohmer Dirk-Michael Zahm Christian Jackisch Marion van Mackelenbergh J örg Thomalla Frederik Marm é Jens Huober Volkmar M üller Christian Schem Anja M üller Elmar Stick Source Type: research